Last edition
News about Consultants
TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid
The TB Alliance has granted Lupin a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug BPaL regimen. Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories
Consultants | 07/09/2021 | By Darshana | 607
Centrient Pharmaceuticals completes acquisition of Astral SteriTech
With the addition of Astral SteriTech's semi-synthetic cephalosporin and semi-synthetic penicillin sterile injectable finished dosage forms to Centrient's product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine
Consultants | 03/09/2021 | By Darshana | 1071
Novartis secures approval in China for Cosentyx
Novartis has announced that the China National Medical Products Administration (NMPA) has further approved Cosentyx for the treatment of moderate-to-severe plaque psoriasis in paediatric patients
Consultants | 19/08/2021 | By Darshana | 565
Test At Home (TAH), backed by global VC firm Antler, is a medical technology startup, has completed clinical trial on its proprietary 'Lollipop-like' device that enables individuals to self-collect saliva sample for Covid-19 testing with around 95% accuracy based on initial clinical data
Consultants | 17/08/2021 | By Darshana | 262
Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors
Pharma major Lupin Limited (Lupin) announced today the appointment of Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha as Independent Directors.
Consultants | 13/08/2020 | By Darshana | 459
Even as the number of COVID-19 cases in Maharashtra is increasing with each passing day and urgently needs remdesivir injections for critically ill patients, the Mumbai-based VJ Farma has sought no objection certificate (NOC) from Drugs Controller General of India (DCGI) for importing 5,000 remdesivir vials from a Bangladesh firm Eskayef Pharmaceuticals
Consultants | 09/07/2020 | By Darshana | 469
Thyrocare launches coronavirus antibody tests across India, to conduct over 1,500 tests daily
Thyrocare, India's leading diagnostic laboratory chain, has announced the availability of COVID Antibody Test to check your body's response to COVID-19 infection. It is not a diagnostic test, but is used for sero-surveillance to understand whether a person has encountered the infection in the recent past
Consultants | 05/07/2020 | By Darshana | 453
The U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of the FDA's Oncology Center of Excellence (OCE). Through a new website, Project Patient Voice creates a consistent source of publicly available information describing patient-reported symptoms from cancer trials
Consultants | 24/06/2020 | By Darshana | 407
FDA Approves Drug to Treat Infants and Children with HIV
Today, the U.S. Food and Drug Administration approved Tivicay (dolutegravir) tablets and Tivicay PD (dolutegravir) tablets for suspension to treat HIV-1 infection in pediatric patients at least four weeks old and weighing at least 3 kg (6.61 pounds) in combination with other antiretroviral treatments
Consultants | 15/06/2020 | By Darshana | 371
Coronavirus: WHO stops trial of hydroxycloroquine due to safety concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday
Consultants | 26/05/2020 | By Darshana | 444
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy